NCT00909766 - Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects | Biotech Hunter

Enrollment

113

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Obesity

Interventions

DRUG

BMS-830216

Capsules, Oral, 30 mg, once daily, 28 days

DRUG

BMS-830216

Capsules, Oral, 100 mg, once daily, 28 days

DRUG

BMS-830216

Capsules, oral, 300 mg, once daily, 28 days

DRUG

BMS-830216

Capsules, oral, 600 mg, once daily 28 days

DRUG

BMS-830216

Capsules, oral, 1200 mg, once daily, 28 days

DRUG

BMS-830216

Capsules, Oral, to be determined, once daily, 28 days

DRUG

Placebo

Capsules, Oral, 0 mg, once daily, 28 days

Trial Locations (1)

Pennington Biomedical Research Center, Baton Rouge